Tilray Brands, Indivior, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are publicly traded shares of companies involved in the cultivation, production, distribution or ancillary services of the legal cannabis industry. Investing in these stocks gives individuals exposure to both medical and recreational marijuana markets as well as related businesses like biotech, retail and equipment suppliers. Their performance is often influenced by regulatory changes, market sentiment and evolving consumer trends. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read Our Latest Research Report on INDV
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
Further Reading
- MarketBeat’s Top Five Stocks to Own in September 2025
- Why CoreWeave’s NVIDIA Deal Creates a Deep Moat for AI Investors
- CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges
- This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge
- This Defense Stock Is Up 113% This Year—Is It Still a Buy?
- Rezolute Stock: FDA Fast Track Fuels 2025 Breakout